Search Results - "Longo, Christopher"

Refine Results
  1. 1

    The cost and value of cancer medicines in Ontario, Canada by Longo, Christopher J

    Published in The lancet oncology (01-04-2024)
    “…There are published consumer price index subindexes5 for health and personal care that could have been used to report all costs in constant Canadian dollars,…”
    Get full text
    Journal Article
  2. 2

    Societal Perspectives and Real-World Cost-Effectiveness: Expanding the Scope of Health Economics Inquiry by Longo, Christopher J

    Published in Current oncology (Toronto) (23-12-2022)
    “…Economic evaluations of health technologies for cancer are frequently seen in the literature, but not all economic perspectives have the same frequency [...]…”
    Get full text
    Journal Article
  3. 3

    Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review by Longo, Christopher J., Fitch, Margaret I., Banfield, Laura, Hanly, Paul, Yabroff, K. Robin, Sharp, Linda

    Published in Supportive care in cancer (01-10-2020)
    “…Purpose Financial toxicity related to cancer diagnosis and treatment is a common issue in developed countries. We seek to systematically summarize the extent…”
    Get full text
    Journal Article
  4. 4

    Linking Intermediate to Final "Real-World" Outcomes: Is Financial Toxicity a Reliable Predictor of Poorer Outcomes in Cancer? by Longo, Christopher J

    Published in Current oncology (Toronto) (02-04-2022)
    “…Traditionally, economic evaluations are based on clinical trials with well-defined patient populations that exclude many patient types. By contrast, studies…”
    Get full text
    Journal Article
  5. 5

    Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies by Fitch, Margaret I., Sharp, Linda, Hanly, Paul, Longo, Christopher J.

    Published in Journal of cancer survivorship (01-04-2022)
    “…Purpose Understanding how patients and families experience, respond to, and cope with the financial burden associated with cancer could assist in identifying…”
    Get full text
    Journal Article
  6. 6

    Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database by Maity, Tuhin, Longo, Christopher

    Published in BMC health services research (13-11-2021)
    “…Background The prediction of the real-world cost of adverse drug reactions (ADRs) has historically relied on the data from randomized controlled trials (RCT)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cancer patients’ perspectives on financial burden in a universal healthcare system: Analysis of qualitative data from participants from 20 provincial cancer centers in Canada by Fitch, Margaret I., Longo, Christopher J., Chan, Raymond Javan

    Published in Patient education and counseling (01-04-2021)
    “…•Even within a universal health care system, a significant proportion of cancer patients experienced financial struggle and resulting emotional distress.•The…”
    Get full text
    Journal Article
  9. 9

    Exploring the impact of out-of-pocket costs on the quality of life of Canadian cancer patients by Fitch, Margaret, Longo, Christopher J.

    Published in Journal of psychosocial oncology (03-09-2018)
    “…Objective: To explore cancer patients' perspective about the impact of financial burden on quality of life. Methods: A qualitative descriptive approach was…”
    Get full text
    Journal Article
  10. 10

    Emerging Understanding About the Impact of Financial Toxicity Related to Cancer: Canadian Perspectives by Fitch, Margaret I., Longo, Christopher J.

    Published in Seminars in oncology nursing (01-08-2021)
    “…This article offers an overall summary of the current situation concerning cancer-related financial toxicity from the perspective of Canadian patents and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Understanding the full breadth of cancer-related patient costs in Ontario: a qualitative exploration by Longo, Christopher J., Fitch, Margaret, Grignon, Michel, McAndrew, Alison

    Published in Supportive care in cancer (01-11-2016)
    “…Objective This research informs existing work by examining the full scope of out-of-pocket costs and lost income, patients’ private insurance behaviors, and…”
    Get full text
    Journal Article
  13. 13

    Patient and Family Financial Burden in Cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada by Longo, Christopher J, Maity, Tuhin, Fitch, Margaret I, Young, Jesse T

    Published in Current oncology (Toronto) (01-05-2024)
    “…This study aimed to examine provincial differences in patient spending for cancer care and reductions in household spending including decisions to forego care…”
    Get full text
    Journal Article
  14. 14
  15. 15

    When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing by Balderrama, Fanor, Schwartz, Lisa J., Longo, Christopher J.

    Published in Health care analysis (01-06-2020)
    “…The most common solutions to the problem of high pharmaceutical prices have taken the form of regulations, price negotiations, or changes in drug coverage by…”
    Get full text
    Journal Article
  16. 16

    Relationships between Canadian adult cancer survivors’ annual household income and emotional/practical concerns, help‐seeking and unmet needs by Nicoll, Irene, Lockwood, Gina, Longo, Christopher J., Loiselle, Carmen G., Fitch, Margaret I.

    Published in Health & social care in the community (01-07-2022)
    “…The objective of this study was to explore the relationship among income and emotional/practical concerns, help‐seeking and unmet needs for cancer survivors…”
    Get full text
    Journal Article
  17. 17

    Relationship between income and concerns about physical changes and help-seeking by older adult cancer survivors: a secondary analysis by Nicoll, Irene, Lockwood, Gina, Strohschein, Fay J, Fitch, Lauren, Longo, Christopher J, Newton, Lorelei, Fitch, Margaret I

    Published in BMC geriatrics (29-03-2023)
    “…Globally, the number of older adults surviving cancer is anticipated to grow rapidly over the next decades. Cancer and its treatment can leave survivors with a…”
    Get full text
    Journal Article
  18. 18

    Impact of Income on Physical Concerns, Help Seeking, and Unmet Needs of Adult Cancer Survivors by Nicoli, Irene, Lockwood, Gina, Fitch, Lauren, Longo, Christopher J., Fitch, Margaret I.

    Published in Physiotherapy Canada (01-11-2023)
    “…PurposeCancer treatment can have consequences for individuals which may have profound impact on daily living. Accessing assistance can be problematic. This…”
    Get full text
    Journal Article
  19. 19

    A prospective, observational registry of patients with severe sepsis : The Canadian Sepsis Treatment and Response Registry by MARTIN, Claudio M, PRIESTAP, Fran, FISHER, Harold, FOWLER, Robert A, HEYLAND, Daren K, KEENAN, Sean P, LONGO, Christopher J, MORRISON, Teresa, BENTLEY, Diane, ANTMAN, Neil

    Published in Critical care medicine (2009)
    “…To determine the location of acquisition, timing, and outcomes associated with severe sepsis in community and teaching hospital critical care units…”
    Get full text
    Journal Article
  20. 20

    Elective Repeat Caesarean Section in Low-Risk Women—Economic Evaluation Comparing Births Before vs. After 39 Weeks Gestation in Ontario, Canada by Longo, Christopher J., Harrold, JoAnn, Dunn, Sandra, Smith, Graeme

    “…To undertake an economic analysis of repeat Caesarean births in low-risk women (LRW) not in labour in Ontario who delivered at 37–38 weeks (<39 weeks) vs…”
    Get full text
    Journal Article